# Naloxone Auto-injection in Healthy Volunteers

> **NCT05099614** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 20 (actual)

## Conditions studied

- Overdose Antidote

## Interventions

- **COMBINATION_PRODUCT:** Naloxone hydrochloride injection solution, SmartDose wearable auto injector and mobile respiratory sensing system

## Key facts

- **NCT ID:** NCT05099614
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-10
- **Primary completion:** 2021-04-05
- **Final completion:** 2021-04-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099614, "Naloxone Auto-injection in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05099614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*